TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy
Molgora, Martina, Esaulova, Ekaterina, Vermi, William, Hou, Jinchao, Chen, Yun, Luo, Jingqin, Brioschi, Simone, Bugatti, Mattia +13 more·2020·Cell
Cited by (657)
Items 101–200 of 657
- Tumor microenvironment and immunotherapy for triple-negative breast cancerZi-Jie Guo, Zi-Yu Zhu, Xi-Xi Lin, Shenkangle Wang, Yi-Hong Wen, Lin-Bo Wang, Li-Li Zhi, Ji-Chun Zhou · 2024 · Biomarker Research
- A transcriptional metastatic signature predicts survival in clear cell renal cell carcinomaAdele M. Alchahin, Shenglin Mei, Ιωάννα Τσέα, Taghreed Hirz, Youmna Sami Kfoury, Douglas M. Dahl, Chin‐Lee Wu, Alexander O. Subtelny, Shulin Wu, David T. Scadden et al. · 2022 · Nature Communications
- Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironmentSayali Onkar, Jian Cui, Jian Zou, Carly Cardello, Anthony Richard Cillo, Mostofa Rafid Uddin, April Sagan, Marion Joy, Hatice U. Osmanbeyoglu, Katherine L. Pogue–Geile et al. · 2023 · Nature Cancer
- Molecular Subgroups of Intrahepatic Cholangiocarcinoma Discovered by Single-Cell RNA Sequencing–Assisted Multiomics AnalysisXuanwen Bao, Qiong Li, Jinzhang Chen, Diyu Chen, Chanqi Ye, Xiaomeng Dai, Yanfang Wang, Xin Li, Xiaoxiang Rong, Fei Cheng et al. · 2022 · Cancer Immunology Research
- Targeted inducible delivery of immunoactivating cytokines reprograms glioblastoma microenvironment and inhibits growth in mouse modelsFilippo Birocchi, Melania Cusimano, Federico Rossari, Stefano Beretta, Paola M. V. Rancoita, Anna Ranghetti, Stefano Colombo, Barbara Costa, Peter E. Angel, Francesca Sanvito et al. · 2022 · Science Translational Medicine
- Anti-CTLA-4 antibodies drive myeloid activation and reprogram the tumor microenvironment through FcγR engagement and type I interferon signalingIdo Yofe, Tomer Landsberger, Adam Yalin, Isabelle Solomon, Cristóbal Costoya, Dafne Franz Demane, Mansi Shah, Eyal David, Chamutal Borenstein, Oren Barboy et al. · 2022 · Nature Cancer
- Single-cell resolution characterization of myeloid-derived cell states with implication in cancer outcomeGabriela Rapozo Guimarães, Giovanna Resk Maklouf, Cristiane Esteves Teixeira, Leandro de Oliveira Santos, Nayara Gusmão Tessarollo, Nayara Evelin de Toledo, Alessandra Freitas Serain, Cristóvão Antunes de Lanna, Marco Antônio M. Pretti, Jéssica Gonçalves Vieira da Cruz et al. · 2024 · Nature Communications
- TREM2: A new player in the tumor microenvironmentMartina Molgora, Yizhou A. Liu, Marco Colonna, Marina Cella · 2023 · Seminars in Immunology
- Macrophage diversity in human cancers: New insight provided by single-cell resolution and spatial contextMilitsa A. Rakina, Irina Larionova, Julia G. Kzhyshkowska · 2024 · Heliyon
- TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activityCui, Huachun, Banerjee, Sami, Xie, Na, Hussain, Musaddique, Jaiswal, Ashish, Liu, Hongli, Kulkarni, Tejaswini, Antony, Veena B., Liu, Rui-Ming, Colonna, Marco et al. · 2025 · Nature Communications
- Function of TREM1 and TREM2 in Liver-Related DiseasesHuifang Sun, Jianguo Feng, Liling Tang · 2020 · Cells
- Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinomaIva Truxová, David Cibula, Radek Špíšek, Jitka Palich Fucikova · 2023 · Journal for ImmunoTherapy of Cancer
- TREM2/β-catenin attenuates NLRP3 inflammasome-mediated macrophage pyroptosis to promote bacterial clearance of pyogenic bacteriaWang, Yi, Cao, Can, Zhu, Yanting, Fan, Huifeng, Liu, Qiaojuan, Liu, Yiting, Chen, Kang, Wu, Yongjian, Liang, Siping, Li, Meiyu et al. · 2022 · Cell Death & Disease
- Targeting macrophages: a novel treatment strategy in solid tumorsMengmeng Liu, Lina Liu, Yongping Song, Wei Li, Linping Xu · 2022 · Journal of Translational Medicine
- Microglia at sites of atrophy restrict the progression of retinal degeneration via galectin-3 and Trem2Yu Chen, Eleonora Maries Lad, Rose Mathew, Nobuhiko Shiraki, Sejiro Littleton, Yun Chen, Jinchao Hou, Kai Schlepckow, Simone Degan, Lindsey A. Chew et al. · 2024 · The Journal of Experimental Medicine
- Macrophages and T cells in metabolic disorder-associated cancersDaniel Taranto, D. Kloosterman, L. Akkari · 2024 · Nature Reviews. Cancer
- TREM2 marks tumor-associated macrophagesKyohei Nakamura, Mark John Smyth · 2020 · Signal Transduction and Targeted Therapy
- TREM2 Mediates Microglial Anti-Inflammatory Activations in Alzheimer’s Disease: Lessons Learned from TranscriptomicsFeng Xue, Heng Du · 2021 · Cells
- Timing and location dictate monocyte fate and their transition to tumor-associated macrophagesGarett Dunsmore, Wei Guo, Ziyi Li, David Alejandro Bejarano, Rhea Pai, Katharine Lu Yang, Immanuel Kwok, Leonard Tan, Melissa Shu Feng Ng, Carlos de la Calle‐Fabregat et al. · 2024 · Science Immunology
- Cytocidal macrophages in symbiosis with CD4 and CD8 T cells cause acute diabetes following checkpoint blockade of PD-1 in NOD miceHao Hu, Pavel N. Zakharov, Orion J. Peterson, Emil R. Unanue · 2020 · Proceedings of the National Academy of Sciences
- Midkine expression by stem-like tumor cells drives persistence to mTOR inhibition and an immune-suppressive microenvironmentYan Tang, David J. Kwiatkowski, Elizabeth P. Henske · 2022 · Nature Communications
- The tumour microenvironment in pancreatic cancer — new clinical challenges, but more opportunitiesHeng‐Chung Kung, Kevin Zheng, Jacquelyn W. Zimmerman, Lei Zheng · 2025 · Nature Reviews Clinical Oncology
- Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer SubtypesLaura Ardighieri, Francesco Missale, Mattia Bugatti, Luisa Benerini Gatta, Irene Pezzali, Matilde Monti, Stefano Gottardi, Laura Zanotti, Eliana Bignotti, Antonella Ravaggi et al. · 2021 · Frontiers in Immunology
- Exploring the Impact of TREM2 in Tumor-Associated MacrophagesDarya Khantakova, Simone Brioschi, Martina Molgora · 2022 · Vaccines
- Targeting TREM1 augments antitumor T cell immunity by inhibiting myeloid-derived suppressor cells and restraining anti–PD-1 resistanceAshwin Ajith, Kenza Mamouni, Daniel David Horuzsko, Abu Musa, Amiran Dzutsev, Jennifer R. Fang, Ahmed Chadli, Xingguo Zhu, Iryna Lebedyeva, Giorgio Trinchieri et al. · 2023 · Journal of Clinical Investigation
- Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesionsShenglin Mei, Adele M. Alchahin, Ιωάννα Τσέα, Youmna Sami Kfoury, Taghreed Hirz, Nathan Elias Jeffries, Ting Zhao, Yanxin Xu, Hanyu Zhang, Hirak Sarkar et al. · 2024 · Genome Medicine
- Turning enemies into allies—reprogramming tumor-associated macrophages for cancer therapyMartina Molgora, Marco Colonna · 2021 · Med
- Reprogramming of Hepatic Metabolism and Microenvironment in Nonalcoholic SteatohepatitisLiangyou Rui, Jiandie D. Lin · 2022 · Annual Review of Nutrition
- Sopa: a technology-invariant pipeline for analyses of image-based spatial omicsQuentin Blampey, Kevin Mulder, Margaux Gardet, Stergios Christodoulidis, Charles‐Antoine Dutertre, Fabrice André, Florent Ginhoux, Paul-Henry Cournède · 2024 · Nature Communications
- Targeting tumour-reprogrammed myeloid cells: the new battleground in cancer immunotherapyFrancesco De Sanctis, Annalisa Adamo, Stefania Canè, Stefano Ugel · 2022 · Seminars in Immunopathology
- Involvement of protumor macrophages in breast cancer progression and characterization of macrophage phenotypesYoshihiro Komohara, Daisuke Kurotaki, Hirotake Tsukamoto, Yuko Miyasato, Hiromu Yano, Cheng Pan, Yutaka Yamamoto, Yukio Fujiwara · 2023 · Cancer Science
- TREM2 deficiency reprograms intestinal macrophages and microbiota to enhance anti–PD-1 tumor immunotherapyDi Luccia, Blanda, Molgora, Martina, Khantakova, Darya, Jaeger, Natalia, Chang, Hao-Wei, Czepielewski, Rafael S., Helmink, Beth A., Onufer, Emily J., Fachi, José L., Bhattarai, Bishan et al. · 2024 · Science Immunology
- Holistic Characterization of Tumor Monocyte-to-Macrophage Differentiation Integrates Distinct Immune Phenotypes in Kidney CancerAdriana M. Mujal, Alexis J. Combes, Arjun A. Rao, Mikhail Binnewies, Bushra Samad, Jessica Tsui, Alexandre Boissonnas, Joshua L. Pollack, Rafael José Argüello, Maxwell V. Meng et al. · 2022 · Cancer Immunology Research
- Immunotherapy in soft tissue and bone sarcoma: unraveling the barriers to effectivenessMyrofora Panagi, Pampina Pilavaki, Anastasia Constantinidou, Triantafyllos Stylianopoulos · 2022 · Theranostics
- Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastomaMekenzie Peshoff, Pravesh Gupta, Shivangi Oberai, Rakesh Trivedi, Hiroshi G. Katayama, Prashanth Chakrapani, Minghao Dang, Simona Migliozzi, Joy Gumin, Divya B Kadri et al. · 2024 · Neuro-Oncology
- Lactation-associated macrophages exist in murine mammary tissue and human milkDilay Cansever, Ekaterina Petrova, Sinduya Krishnarajah, Caroline Mussak, Christina A. Welsh, Wiebke Mildenberger, Kevin Mulder, Victor Kreiner, E. Roussel, Sebastian A. Stifter et al. · 2023 · Nature Immunology
- Apolipoprotein E controls Dectin-1-dependent development of monocyte-derived alveolar macrophages upon pulmonary β-glucan-induced inflammatory adaptationHannah Theobald, David Alejandro Bejarano, Natalie Katzmarski, Jessica Haub, Jonas Schulte-Schrepping, Jiangyan Yu, Kevin E. Bassler, A. L. Ament, Collins Osei-Sarpong, Federica Piattini et al. · 2024 · Nature Immunology
- Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint InhibitionChristopher A Alvarez-Breckenridge, Samuel C. Markson, Jackson H. Stocking, Naema Nayyar, Matt Lastrapes, Matthew R. Strickland, Albert Eusik Kim, Magali A. de Sauvage, Ashish Dahal, Juliana M. Larson et al. · 2022 · Cancer Immunology Research
- Glycosylation-driven programs coordinate immunoregulatory and pro-angiogenic functions of myeloid-derived suppressor cellsAda Gabriela Blidner, Camila Agustina Bach, Pablo A. García, Joaquin Pedro Merlo, Alejandro J. Cagnoni, Nadia Bannoud, Montana N Manselle Cocco, Juan M. Pérez‐Sáez, Nicolás A. Pinto, Nicolás I. Torres et al. · 2025 · Immunity
- Neuroblastoma Formation Requires Unconventional CD4 T Cells and Arginase-1–Dependent Myeloid CellsLee-Ann Van de Velde, Emma Kaitlynn Allen, Jeremy Chase Crawford, Taylor Leigh Wilson, Clifford S. Guy, Marion Russier, Leonie Zeitler, Armita Bahrami, David Finkelstein, S. William Pelletier et al. · 2021 · Cancer Research
- Mapping Breast Cancer Microenvironment Through Single-Cell OmicsZhenya Tan, Kan Chen, Minqiong Sun, Fan Yang, Mandy Wong, Siying Wang, Hong Zheng · 2022 · Frontiers in Immunology
- Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapyBirgit Fendl, Anna Sophie Berghoff, Matthias Preusser, B. Maier · 2023 · ESMO Open
- Transcriptional space-time mapping identifies concerted immune and stromal cell patterns and gene programs in wound healing and cancerK. Hu, Nicholas F. Kuhn, Tristan Courau, Jessica L. Tsui, B. Samad, Patrick K. Ha, J. Kratz, A. Combes, M. Krummel · 2023 · Cell Stem Cell
- Myeloid progenitor dysregulation fuels immunosuppressive macrophages in tumoursSamarth Hegde, B. Giotti, Brian Y. Soong, Laszlo Halasz, Jessica Le Berichel, Maximilian M. Schaefer, Benoît Kloeckner, R. Mattiuz, Matthew D. Park, A. Magen et al. · 2025 · Nature
- Immunosuppressive landscape in hepatocellular carcinoma revealed by single-cell sequencingYi Bai, Dapeng Chen, Chuanliang Cheng, Zhongmin Li, Hao Chi, Yuliang Zhang, Xiaoyu Zhang, Shaohai Tang, Qiang Zhao, Yamin Zhang et al. · 2022 · Frontiers in Immunology
- The therapeutic potential of TREM2 in cancerElysa M. Wolf, B. Fingleton, A. Hasty · 2022 · Frontiers in Oncology
- Immunogenomic analysis of human brain metastases reveals diverse immune landscapes across genetically distinct tumorsÁngel F. Álvarez-Prado, Roeltje R. Maas, Klara Soukup, Florian Klemm, Mara Kornete, Fanny S. Krebs, Vincent Zoete, Sabina Berezowska, Jean‐Philippe Brouland, Andreas Felix Hottinger et al. · 2023 · Cell Reports Medicine
- TREM2 Depletion in Pancreatic Cancer Elicits Pathogenic Inflammation and Accelerates Tumor Progression via Enriching IL-1β+ MacrophagesDaowei Yang, Xinlei Sun, Hua Wang, Ignacio Ivan Wistuba, Huamin Wang, Anirban Maitra, Yang Chen · 2025 · Gastroenterology
- Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastomaWilliam H. Tomaszewski, Jessica Waibl Polania, Molly A. Chakraborty, Jonathan Perera, Jeremy J. Ratiu, Alexandra M. Hoyt-Miggelbrink, Donald Patrick McDonnell, Mustafa Khasraw, David M. Ashley, Peter Edward Fecci et al. · 2022 · Nature Communications
- At the Interface of Tumor-Associated Macrophages and Fibroblasts: Immune-Suppressive Networks and Emerging Exploitable TargetsTimperi, Eleonora, Croizer, Hugo, Khantakova, Darya, Rana, Mhaidly, Molgora, Martina, Guerriero, Jennifer L., Mechta-Grigoriou, Fatima, Romano, Emanuela · 2024 · Clinical Cancer Research
- Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic CancerRobert H. Vonderheide, Adham Sean Bear · 2020 · Frontiers in Immunology
- Single-nucleus RNA sequencing of pre-malignant liver reveals disease-associated hepatocyte state with HCC prognostic potentialRodrigo Carlessi, Elena Denisenko, Ebru Boslem, Julia Köhn‐Gaone, Nathan Main, N. Dianah B. Abu Bakar, Gayatri D. Shirolkar, Matthew Jones, Aaron B. Beasley, Daniel Poppe et al. · 2023 · Cell Genomics
- Revealing the role of SPP1+ macrophages in glioma prognosis and therapeutic targeting by investigating tumor-associated macrophage landscape in grade 2 and 3 gliomasWenshu Tang, Cario W.S. Lo, Wei Ma, Annie Tsz-Wai Chu, Amy H.Y. Tong, Brian Hon‐Yin Chung · 2024 · Cell & Bioscience
- NF-κB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironmentCarlos de la Calle‐Fabregat, Josep Calafell-Segura, Margaux Gardet, Garett Dunsmore, Kevin Mulder, Laura Ciudad, Aymeric Silvin, Joaquim Moreno‐Càceres, Angel Luis Corbí, Cristina Muñoz‐Pinedo et al. · 2024 · Science Advances
- Targeting the Tumor Microenvironment: A Close Up of Tumor-Associated Macrophages and NeutrophilsMassimo Russo, Claudia Nastasi · 2022 · Frontiers in Oncology
- A Population of TIM4+FOLR2+ Macrophages Localized in Tertiary Lymphoid Structures Correlates to an Active Immune Infiltrate Across Several Cancer TypesMattia Bugatti, Marco Bergamini, Francesco Missale, Matilde Monti, Laura Ardighieri, Irene Pezzali, Sara Picinoli, Nicoletta Caronni, Yoann Missolo-Koussou, Julie Helft et al. · 2022 · Cancer Immunology Research
- TREM2 scFv‐Engineering Escherichia coli Displaying Modulation of Macrophages to Boost Cancer Radio‐ImmunotherapyYifan Wang, Anqi Dong, Jianping Man, Hua Chen, Wenhao Shen, Lei Wang, Hongli Yang, Lin Hu, Kai Yang · 2025 · Advanced Materials
- Metabolism archetype cancer cells induce protumor TREM2+ macrophages via oxLDL-mediated metabolic interplay in hepatocellular carcinomaTianhao Chu, Gui‐Qi Zhu, Zheng Tang, Wei‐Feng Qu, Rui Yang, Haiting Pan, Yì Wáng, Ruilin Tian, Leilei Chen, Zhiqi Guan et al. · 2025 · Nature Communications
- Apatinib remodels the immunosuppressive tumor ecosystem of gastric cancer enhancing anti-PD-1 immunotherapyQicong Luo, Zinan Dong, Wen Xie, Xiaoteng Fu, Lingyun Lin, Qiang Zeng, Yinggang Chen, Guodong Ye, Maoli Chen, Huiyu Hu et al. · 2023 · Cell Reports
- ZEB2 is a master switch controlling the tumor-associated macrophage programFadi Sheban, Truong San Phan, Ken Xie, Florian Ingelfinger, Chamutal Gur, Yuval Shapir Itai, Ronnie Blecher‐Gonen, Chunsong Yu, Roberto Avellino, Paulina Chalan et al. · 2025 · Cancer Cell
- Tumor associated macrophage in HPV+ tumors: Between immunosuppression and inflammationLaurent Gorvel, Daniel Olive · 2022 · Seminars in Immunology
- Efferocytosis by macrophages in physiological and pathological conditions: regulatory pathways and molecular mechanismsYan-Ran Sheng, Wen-Ting Hu, Si-Man Chen, Xiao-Yong Zhu · 2024 · Frontiers in Immunology
- Vax-Innate: improving therapeutic cancer vaccines by modulating T cells and the tumour microenvironmentFaezzah Baharom, Dalton Hermans, Lélia Delamarre, Robert A. Seder · 2024 · Nature reviews. Immunology
- Single-cell RNA sequencing reveals immune microenvironment niche transitions during the invasive and metastatic processes of ground-glass nodules and part-solid nodules in lung adenocarcinomaYifeng Ren, Qiong Ma, Xiao Feng Zeng et al. · 2024 · Molecular Cancer
- An integrated overview of the immunosuppression features in the tumor microenvironment of pancreatic cancerJinglong Guo, Siyue Wang, Qi Gao · 2023 · Frontiers in Immunology
- What Happens to the Immune Microenvironment After PD-1 Inhibitor Therapy?Qingyi Wang, Bin Xie, Shuang Liu, Ying Shi, Yongguang Tao, Desheng Xiao, Wenxiang Wang · 2021 · Frontiers in Immunology
- Fibroblast growth factor receptor 3 mutation attenuates response to immune checkpoint blockade in metastatic urothelial carcinoma by driving immunosuppressive microenvironmentYuxuan Song, Yun Peng, Caipeng Qin, Yulong Wang, Wenbo Yang, Yiqing Du, Tao Xu · 2023 · Journal for ImmunoTherapy of Cancer
- Immune Dysregulation in ObesityZewen Jiang, Chihiro Tabuchi, Sarah G. Gayer, Sagar P. Bapat · 2025 · Annual Review of Pathology Mechanisms of Disease
- TREM2 is associated with tumor immunity and implies poor prognosis in gliomaMingchen Yu, Yuanhao Chang, You Zhai, Bo Pang, Peng Wang, Guanzhang Li, Tao Jiang, Fan Zeng · 2023 · Frontiers in Immunology
- Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2 and Elevated TREM-1 Associates With Disease Progression in Renal Cell CarcinomaJill W. Ford, Marieli Gonzalez-Cotto, Alexander W. Macfarlane, Suraj Peri, O. M. Zack Howard, Jeffrey J. Subleski, Karen J Ruth, Mohammed Haseebuddin, Tahseen Al‐Saleem, Youfeng Yang et al. · 2022 · Frontiers in Oncology
- The role of tumor-associated macrophages in oral squamous cell carcinomaYiwen Xue, Xiao Jie Song, Siyu Fan, Runzhi Deng · 2022 · Frontiers in Physiology
- Colorectal Cancer Immunotherapy: State of the Art and Future DirectionsCornista, Alyssa Mauri, Giolito, Maria Virginia, Baker, Kristi, Hazime, Hajar, Dufait, Inès, Datta, Jashodeep, Khumukcham, Saratchandra Singh, De Ridder, Mark, Roper, Jatin, Abreu, Maria T. et al. · 2023 · Gastro Hep Advances
- Advanced insights on tumor-associated macrophages revealed by single-cell RNA sequencing: The intratumor heterogeneity, functional phenotypes, and cellular interactionsSen Yang, Mengyi Wang, Yuze Hua, Jiayi Li, Huaijin Zheng, Ming Cui, Nan Huang, Qiaofei Liu, Quan Liao · 2024 · Cancer Letters
- Neutral ceramidase regulates breast cancer progression by metabolic programming of TREM2-associated macrophagesRui Sun, Chao Lei, Zhishan Xu, Xuemei Gu, Liu Huang, Liang Chen, Yi Tan, Min Peng, Kavitha Yaddanapudi, Leah J. Siskind et al. · 2024 · Nature Communications
- Myeloid Trem2 ameliorates the progression of metabolic dysfunction-associated steatotic liver disease by regulating macrophage pyroptosis and inflammation resolutionWenjie Yu, Yu Zhang, Linfeng Sun, Wei Huang, Xiangdong Li, Nan L. Xia, Xuejiao Chen, Likalamu Pascalia Wikana, Yuhao Xiao, Minhao Chen et al. · 2024 · Metabolism
- Knockdown of trem2 promotes proinflammatory microglia and inhibits glioma progression via the JAK2/STAT3 and NF-κB pathwaysYunji Yan, Shengwei Bai, Hongxi Han, Junqiang Dai, Liang Niu, Hongyu Wang, Qiang Dong, Hang Yin, Guoqiang Yuan, Yawen Pan · 2024 · Cell Communication and Signaling
- Macrophages: Targets for next-generation cancer immunotherapyXiaoqi Sun, Matthew D. Park, Miriam Mérad, Brian D. Brown · 2026 · Cancer Cell
- Cystatin C is glucocorticoid responsive, directs recruitment of Trem2+ macrophages, and predicts failure of cancer immunotherapyKleeman, Sam O., Thakir, Tuba Mansoor, Demestichas, Breanna, Mourikis, Nicholas, Loiero, Dominik, Ferrer, Miriam, Bankier, Sean, Riazat-Kesh, Yosef J.R.A., Lee, Hassal, Chantzichristos, Dimitrios et al. · 2023 · Cell Genomics
- Immunosuppressive Cell Subsets and Factors in Myeloid LeukemiasJulian Swatler, Laura Turos-Korgul, Ewa Kozłowska, Katarzyna Piwocka · 2021 · Cancers
- Multifunctional nanoparticles precisely reprogram the tumor microenvironment and potentiate antitumor immunotherapy after near-infrared-II light-mediated photothermal therapyYanni Ge, Jiaojiao Zhang, Kai Jin, Ziqiang Ye, Wei Wang, Zhuxian Zhou, Juan Ye · 2023 · Acta Biomaterialia
- Targeting tumor‑associated macrophages: Critical players in tumor progression and therapeutic strategies (Review)Pengfei Su, Ou Li, Kun Ke, Zhichen Jiang, Jianzhang Wu, Yuanyu Wang, Yiping Mou, Weiwei Jin · 2024 · International Journal of Oncology
- Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trialsFan Tang, Yan Tie, Yu-Quan Wei, Chongqi Tu, Xiawei Wei · 2021 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulationHongmu Li, Miao Yu, Leqi Zhong, Songjie Feng, Yue Xu, Lu Tang, Chun Jing Wu, Xianzhou Zhang, Ling Gu, Hengyi Diao et al. · 2023 · Frontiers in Immunology
- Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positive metastatic breast cancerColt A. Egelston, Weihua Guo, Susan Elaine Yost, Jin Sun Lee, David L. Rose, Christian Avalos, Jian Ye, Paul Henry Frankel, Daniel D. Schmolze, James Ross Waisman et al. · 2021 · Journal for ImmunoTherapy of Cancer
- Blockading a new NSCLC immunosuppressive target by pluripotent autologous tumor vaccines magnifies sequential immunotherapyHong Wu, Hongyan Li, Yiqiang Liu, Jingchen Liang, Qianshi Liu, Zhigang Xu, Zhongzhu Chen, Kun Zhang, Kun Zhang, Chuan Shan Xu · 2021 · Bioactive Materials
- TRAIL promotes the polarization of human macrophages toward a proinflammatory M1 phenotype and is associated with increased survival in cancer patients with high tumor macrophage contentSinem Günalp, Derya Göksu Helvaci, Aysenur Oner, Ahmet Bursalı, Alessandra Jordano Conforte, Hüseyin Güner, Gökhan Karakülah, Éva Szegezdi, Duygu Sağ · 2023 · Frontiers in Immunology
- TREM2 promotes glioma progression and angiogenesis mediated by microglia/brain macrophagesXuezhen Chen, Yue Zhao, Yimin Huang, Kaichuan Zhu, Fan Zeng, Junyi Zhao, Huaqiu Zhang, Xinzhou Zhu, Helmut Kettenmann, Xianyuan Xiang · 2023 · Glia
- Neurodegenerative fluid biomarkers are enriched in human cervical lymph nodesAdam Al‐Diwani, Nicholas M. Provine, Andrew G. Murchison, Rhiannon Laban, Owen Swann, Ivan G. Koychev, Fintan Sheerin, Sandro Dá Mesquita, Amanda Heslegrave, Henrik Zetterberg et al. · 2024 · Brain
- Scavenger Receptor CD36 in Tumor-Associated Macrophages Promotes Cancer Progression by Dampening Type-I IFN SignalingZiyan Zoe Xu, Alexandra Kuhlmann-Hogan, Shihao Xu, Hubert Tseng, Dan Chen, Shirong Tan, Ming Hua Sun, Victoria Tripple, Marcus Bosenberg, Kathryn Miller‐Jensen et al. · 2024 · Cancer Research
- IL-1β+ macrophages and the control of pathogenic inflammation in cancerNicoletta Caronni, Federica La Terza, Luca Frosio, Renato Ostuni · 2025 · Trends in Immunology
- Defining and targeting tumor-associated macrophages in malignant mesotheliomaLicun Wu, Mikihiro Kohno, Junichi Murakami, Amin Zia, Jonathan Allen, Hana Yun, Meilin Chan, Cristina Baciu, Mingyao Liu, Véronique Serre‐Beinier et al. · 2023 · Proceedings of the National Academy of Sciences
- Metabolism in tumor-associated macrophagesJie Li, Gina M. DeNicola, Brian Ruffell · 2022 · International review of cytology
- Galectin-3 induces pathogenic immunosuppressive macrophages through interaction with TREM2 in lung cancerQiaohua Wang, Yongjian Wu, Guanmin Jiang, Xi Huang · 2024 · Journal of Experimental & Clinical Cancer Research
- Heterogeneity of glioblastoma stem cells in the context of the immune microenvironment and geospatial organizationAryeh Silver, Diana Feier, Tanya Ghosh, Maryam Rahman, Jianping Huang, Matthew R. Sarkisian, Loic P. Deleyrolle · 2022 · Frontiers in Oncology
- TREM2: Keeping Pace With Immune Checkpoint Inhibitors in Cancer ImmunotherapyQiu, Hui, Shao, Zhiying, Wen, Xin, Jiang, Jinghua, Ma, Qinggong, Wang, Yan, Huang, Long, Ding, Xin, Zhang, Longzhen · 2021 · Frontiers in Immunology
- Dietary fat and lipid metabolism in the tumor microenvironmentSwagata Goswami, Qiming Zhang, Cigdem Elif Celik, Ethan M. Reich, Ömer H. Yilmaz · 2023 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
- CHI3L3+ immature neutrophils inhibit anti-tumor immunity and impede immune checkpoint blockade therapy in bone metastasesTao Shi, Wei Liu, Yuting Luo, Kaijie Liang, Shiji Ren, Xueru Song, Fangcen Liu, Chun Lu, Daniel Hirschhorn, Hanbing Wang et al. · 2025 · Cancer Cell
- Functional diversity of disorder-specific macrophages involved in various diseasesYuichi Mitsui, Takashi Satoh · 2025 · Inflammation and Regeneration
- Tumor-associated macrophages, dendritic cells, and neutrophils: biological roles, crosstalk, and therapeutic relevanceMingyi Shen, Yanhua Du, Youqiong Ye · 2021 · Medical Review
- Distinct myeloid population phenotypes dependent on TREM2 expression levels shape the pathology of traumatic versus demyelinating CNS disordersHan Gao, Jiawei Di, Bettina Hjelm Clausen, Nanxiang Wang, Xizhong Zhu, Tianlun Zhao, Yanyu Chang, Mao Pang, Yang Yang, Ronghan He et al. · 2023 · Cell Reports